![Page 1: Glaucoma Case Studies James C. Tsai, M.D. Associate Professor of Ophthalmology Director, Glaucoma Division Edward S. Harkness Eye Institute Columbia University](https://reader035.vdocuments.net/reader035/viewer/2022062806/5697bf8f1a28abf838c8d4fd/html5/thumbnails/1.jpg)
Glaucoma Case Studies
James C. Tsai, M.D.
Associate Professor of Ophthalmology Director, Glaucoma Division Edward S. Harkness Eye Institute Columbia University
![Page 2: Glaucoma Case Studies James C. Tsai, M.D. Associate Professor of Ophthalmology Director, Glaucoma Division Edward S. Harkness Eye Institute Columbia University](https://reader035.vdocuments.net/reader035/viewer/2022062806/5697bf8f1a28abf838c8d4fd/html5/thumbnails/2.jpg)
LD: Clinical History & Exam• 78 y/o woman with glaucoma x 7 months
• PMHx: hypothyroid; Meds: Synthroid, Premarin
• Ocular Hx: negative; on Xalatan qhs OU
• Va: 20/40 OU, Ta: 17 OD, 22 OS (9:25 AM)
• SLE: 2+ NSC OU (+ PXE flakes), A/C D&Q
• Gonio: Grade II-III OU; CCT: 518 OD, 533 OS
• C/D ratio: 0.75 OD, 0.85 OS; thin temporally OU
![Page 3: Glaucoma Case Studies James C. Tsai, M.D. Associate Professor of Ophthalmology Director, Glaucoma Division Edward S. Harkness Eye Institute Columbia University](https://reader035.vdocuments.net/reader035/viewer/2022062806/5697bf8f1a28abf838c8d4fd/html5/thumbnails/3.jpg)
LD: Clinical Assessment
• HVF: OD: WNL, OS: inf. arcuate defect/nasal step
• OCT3: OD: 88.0 microns, OS: 74.75 microns
• Imp: PXF glaucoma w/ uncontrolled IOP (OS>OD) ? Thin CCT OU a risk factor
Target IOP: mid-teens OU
• Treatment Plan: ??
![Page 4: Glaucoma Case Studies James C. Tsai, M.D. Associate Professor of Ophthalmology Director, Glaucoma Division Edward S. Harkness Eye Institute Columbia University](https://reader035.vdocuments.net/reader035/viewer/2022062806/5697bf8f1a28abf838c8d4fd/html5/thumbnails/4.jpg)
Patient: J.D.
• 47 y.o. M w/ COAG & recurrent erosions
• FHx of POAG, Myopia (-4 to -6 D)
• Va 20/20 OU; IOP 18 OD, 16 OS
• cc: grayer & darker vision (OD > OS)
• C/D = 0.8 OD, 0.7 OS (cupped temporally)
• Meds: Betaxolol, Propine
![Page 5: Glaucoma Case Studies James C. Tsai, M.D. Associate Professor of Ophthalmology Director, Glaucoma Division Edward S. Harkness Eye Institute Columbia University](https://reader035.vdocuments.net/reader035/viewer/2022062806/5697bf8f1a28abf838c8d4fd/html5/thumbnails/5.jpg)
Patient: J.D.
• Initial ALT OD, followed by ALT OS
• 1 year later: c/o worse vision (OS > OD)
• Va 20/20 OU; IOP 10 OD, 11 OS
• Diurnal curve: peak of 13 OU
• HVF: worse OU
• C/D = 0.9 OD; 0.85 OS
![Page 6: Glaucoma Case Studies James C. Tsai, M.D. Associate Professor of Ophthalmology Director, Glaucoma Division Edward S. Harkness Eye Institute Columbia University](https://reader035.vdocuments.net/reader035/viewer/2022062806/5697bf8f1a28abf838c8d4fd/html5/thumbnails/6.jpg)
Patient: J.D.
• Neuro-ophthalmology consult:B-12 and folate: WNLCT of orbits: WNL
• 3 months later: IOP 16 OU; cc: OS dimmer
• TBX w/ MMC OS & OD 2 months later
• 5 year F/U: Va 20/20 OU; IOP 10 OD, 9 OSHVF stable OU; No visual loss
![Page 7: Glaucoma Case Studies James C. Tsai, M.D. Associate Professor of Ophthalmology Director, Glaucoma Division Edward S. Harkness Eye Institute Columbia University](https://reader035.vdocuments.net/reader035/viewer/2022062806/5697bf8f1a28abf838c8d4fd/html5/thumbnails/7.jpg)
Visual Fields Pre-Surgery
![Page 8: Glaucoma Case Studies James C. Tsai, M.D. Associate Professor of Ophthalmology Director, Glaucoma Division Edward S. Harkness Eye Institute Columbia University](https://reader035.vdocuments.net/reader035/viewer/2022062806/5697bf8f1a28abf838c8d4fd/html5/thumbnails/8.jpg)
Visual Fields Post-Surgery
![Page 9: Glaucoma Case Studies James C. Tsai, M.D. Associate Professor of Ophthalmology Director, Glaucoma Division Edward S. Harkness Eye Institute Columbia University](https://reader035.vdocuments.net/reader035/viewer/2022062806/5697bf8f1a28abf838c8d4fd/html5/thumbnails/9.jpg)
Case Presentation
• 15 year old boy S/P trauma OD (tennis ball)
• Cc: Blurred vision OD x 3 months
• PMHx: negative
• Va: 20/200 OD, 20/20 OS
• IOP: 4 mm Hg OD, 15 mm OS
• SLE (OD): deep A/C, trace RBCs
![Page 10: Glaucoma Case Studies James C. Tsai, M.D. Associate Professor of Ophthalmology Director, Glaucoma Division Edward S. Harkness Eye Institute Columbia University](https://reader035.vdocuments.net/reader035/viewer/2022062806/5697bf8f1a28abf838c8d4fd/html5/thumbnails/10.jpg)
Gonioscopy
![Page 11: Glaucoma Case Studies James C. Tsai, M.D. Associate Professor of Ophthalmology Director, Glaucoma Division Edward S. Harkness Eye Institute Columbia University](https://reader035.vdocuments.net/reader035/viewer/2022062806/5697bf8f1a28abf838c8d4fd/html5/thumbnails/11.jpg)
Funduscopy
![Page 12: Glaucoma Case Studies James C. Tsai, M.D. Associate Professor of Ophthalmology Director, Glaucoma Division Edward S. Harkness Eye Institute Columbia University](https://reader035.vdocuments.net/reader035/viewer/2022062806/5697bf8f1a28abf838c8d4fd/html5/thumbnails/12.jpg)
Anterior Ultrasound
![Page 13: Glaucoma Case Studies James C. Tsai, M.D. Associate Professor of Ophthalmology Director, Glaucoma Division Edward S. Harkness Eye Institute Columbia University](https://reader035.vdocuments.net/reader035/viewer/2022062806/5697bf8f1a28abf838c8d4fd/html5/thumbnails/13.jpg)
Assessment
• Ocular hypotony OD (with maculopathy)• Cyclodialysis cleft with concomitant
angle recession• Treatment:
1. Argon laser closure of cleft2. Surgical closure of cleft
• Need to monitor for post-op IOP spike(? Concurrent Stage 1 glaucoma tube)
![Page 14: Glaucoma Case Studies James C. Tsai, M.D. Associate Professor of Ophthalmology Director, Glaucoma Division Edward S. Harkness Eye Institute Columbia University](https://reader035.vdocuments.net/reader035/viewer/2022062806/5697bf8f1a28abf838c8d4fd/html5/thumbnails/14.jpg)
74 Year Old Female
Followed in glaucoma clinic for COAGNoted progressive ↓ in visionReferred to retina clinic to evaluate macula
VA: 20/50 OD20/80 OS0.6 log unit RAPD OSColor 1/15 OU
![Page 15: Glaucoma Case Studies James C. Tsai, M.D. Associate Professor of Ophthalmology Director, Glaucoma Division Edward S. Harkness Eye Institute Columbia University](https://reader035.vdocuments.net/reader035/viewer/2022062806/5697bf8f1a28abf838c8d4fd/html5/thumbnails/15.jpg)
Optic Disc Exam
![Page 16: Glaucoma Case Studies James C. Tsai, M.D. Associate Professor of Ophthalmology Director, Glaucoma Division Edward S. Harkness Eye Institute Columbia University](https://reader035.vdocuments.net/reader035/viewer/2022062806/5697bf8f1a28abf838c8d4fd/html5/thumbnails/16.jpg)
Humphrey Visual Fields
![Page 17: Glaucoma Case Studies James C. Tsai, M.D. Associate Professor of Ophthalmology Director, Glaucoma Division Edward S. Harkness Eye Institute Columbia University](https://reader035.vdocuments.net/reader035/viewer/2022062806/5697bf8f1a28abf838c8d4fd/html5/thumbnails/17.jpg)
Neuroimaging
![Page 18: Glaucoma Case Studies James C. Tsai, M.D. Associate Professor of Ophthalmology Director, Glaucoma Division Edward S. Harkness Eye Institute Columbia University](https://reader035.vdocuments.net/reader035/viewer/2022062806/5697bf8f1a28abf838c8d4fd/html5/thumbnails/18.jpg)
Neuroimaging
![Page 19: Glaucoma Case Studies James C. Tsai, M.D. Associate Professor of Ophthalmology Director, Glaucoma Division Edward S. Harkness Eye Institute Columbia University](https://reader035.vdocuments.net/reader035/viewer/2022062806/5697bf8f1a28abf838c8d4fd/html5/thumbnails/19.jpg)
Neuroimaging